http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100056577-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
filingDate 2001-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b84b86cbef97f4033b68d69fe86f3ba
publicationDate 2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20100056577-A
titleOfInvention Contraception methods and dosage forms thereof
abstract The present invention is directed to a plurality of dose periods in which the order is substantially time-limiting, linked and optionally lasts several years, in each case a period of intake over several days and periods of days off with a certain duration within a certain period of time. At least one dosing cycle with and administering a daily dosage unit with one or more contraceptive hormone components, such as estrogen and / or gestagen, at a dose or doses per day, Placebos without any hormonal component at the discontinued periods, or none at all during the discontinued period, at least the duration of the dose or doses of the last dose period last at least 22 days, during the dose period prior to the next dose period. The duration of the dose or doses is in each case shorter than in the next dose. Hormonal contraception methods, and dosage forms for hormonal contraception, in particular for their performance.
priorityDate 2000-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158358447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449185832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554556

Total number of triples: 63.